Researchers successfully tested the safety and preliminary efficacy of stem-cell-derived corneal implants, showing promise ...

Anti-vascular endothelial growth factor (anti-VEGF) therapies for macular neovascularization have been pivotal in decreasing ...

Ongoing patient enrollment in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED); topline results ...

New Delhi: The drug major Sun Pharmaceutical Industries has got approval from the Subject Expert Committee (SEC) functional ...

Opthea is a clinical-stage biotech firm developing Sozinibercept, targeting VEGF-C and VEGF-D for wet AMD, with Phase 3 ...